(RTTNews) - Alector Inc. (ALEC), a biopharmaceutical company, on Monday announced that it has entered into an exclusive global licensing agreement with Genentech for its AL050 program.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.